Cargando…

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage

OBJECTIVES: This study sought to assess the adherence of newly diagnosed hepatocellular carcinoma patients to the Barcelona Clinic Liver Cancer system treatment guidelines and to examine the impact of adherence on the survival of patients in different stages of the disease. METHODS: This study inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kikuchi, Luciana, Chagas, Aline Lopes, Alencar, Regiane S.S.M., Tani, Claudia, Diniz, Marcio A., D’Albuquerque, Luiz A.C., Carrilho, Flair José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2017
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577619/ https://www.ncbi.nlm.nih.gov/pubmed/28954003 http://dx.doi.org/10.6061/clinics/2017(08)01

Ejemplares similares

Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System
por: Kikuchi, Luciana, et al.
Publicado: (2016)

Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
por: Chagas, Aline Lopes, et al.
Publicado: (2015)

Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement
por: Chagas, Aline Lopes, et al.
Publicado: (2020)

Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series
por: Alencar, Regiane Saraiva de Souza Melo, et al.
Publicado: (2022)

Antineutrophil cytoplasmic antibody profiles differ according to type of primary sclerosing cholangitis and autoimmune hepatitis
por: Crescente, Juliana Goldbaum, et al.
Publicado: (2021)

Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment
por: Da Fonseca, Leonardo G., et al.
Publicado: (2023)

Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival
por: Chagas, Aline L., et al.
Publicado: (2019)

Cardiohepatic Interactions - from Humoral Theory to Organ Transplantation
por: Silvestre, Odilson Marcos, et al.
Publicado: (2014)

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Kikuchi, Luciana, et al.
Publicado: (2014)

Feasibility of SBRT for hepatocellular carcinoma in Brazil — a prospective pilot study
por: Chen, Andre Tsin Chih, et al.
Publicado: (2021)

Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: Systematic Review and Meta-Analysis
por: Nacif, Lucas S., et al.
Publicado: (2021)

Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review
por: Toda, Karla Sawada, et al.
Publicado: (2015)

Technological Innovation in Outpatient Assistance for Chronic Liver Disease and Liver Transplant Patients During the Coronavirus Disease Outbreak: A Method to Minimize Transmission
por: Ono, Suzane Kioko, et al.
Publicado: (2020)

HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST
por: NACIF, Lucas Souto, et al.
Publicado: (2018)

Different degrees of malnutrition and immunological alterations according to the aetiology of cirrhosis: a prospective and sequential study
por: Caly, Wanda Regina, et al.
Publicado: (2003)

Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B
por: Abreu, Rodrigo Martins, et al.
Publicado: (2016)

Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
por: Carrilho, Flair Jose, et al.
Publicado: (2010)

Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases
por: Herman, Paulo, et al.
Publicado: (2022)

Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System
por: Wee, Ian J Y, et al.
Publicado: (2022)

Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2018)

Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification
por: Kamiyama, Toshiya, et al.
Publicado: (2017)

Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database
por: Zhang, Nan, et al.
Publicado: (2016)

Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
por: Nassar Junior, Antonio Paulo, et al.
Publicado: (2014)

Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry
por: Passos-Castilho, Ana Maria, et al.
Publicado: (2015)

Brazilian Landscape of Hepatocellular Carcinoma
por: Fonseca, Leonardo G., et al.
Publicado: (2023)

The impact of hepatitis E infection on hepatic fibrosis in liver transplanted patients for hepatitis C infection
por: de Moraes, Adriano Claudio Pereira, et al.
Publicado: (2021)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
por: Kim, Jun Young, et al.
Publicado: (2016)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2020)

Building an outpatient telemedicine care pilot using Scrum-like framework within a medical residency program
por: Bin, Kaio Jia, et al.
Publicado: (2021)

Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective
por: Su, Yu-Wen, et al.
Publicado: (2017)

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma
por: He, Cheng, et al.
Publicado: (2022)

TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma
por: Lima, Henrique A., et al.
Publicado: (2022)

The future of minimally invasive liver resection for hepatocellular carcinoma BCLC stage 0–A
por: Lippert, Trenton, et al.
Publicado: (2023)

Differences in Cost-Effectiveness of Adherence to Nutritional Recommendations: Why, Where, and What?
por: de Mello, Aline Veroneze, et al.
Publicado: (2022)

Feasibility and Efficacy of S-Adenosyl-L-methionine in Patients with HBV-Related HCC with Different BCLC Stages
por: Guo, Tao, et al.
Publicado: (2016)

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy
por: Huang, Pao-Yuan, et al.
Publicado: (2019)

The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
por: Liu, Shun, et al.
Publicado: (2021)

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage
por: Ninomiya, Masashi, et al.
Publicado: (2023)

Significance of CT scan and color Doppler duplex ultrasound in the assessment of Abernethy malformation
por: Nacif, Lucas Souto, et al.
Publicado: (2015)

Sciatic Hernia Mimicking Perianal Abscess in a Cirrhotic Patient
por: Andraus, Wellington, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s6h5id9vku2e19n8g25fcedn7h